2019
DOI: 10.1158/1538-7445.am2019-4549
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 4549: Macrophage-epithelial metabolic crosstalk impairs chemotherapy in pancreatic cancer

Abstract: Pancreatic ductal adenocarcinoma (PDA) remains a leading cause of cancer related death, contrasting a relatively low incidence rate. A principle barrier in PDA treatment is the physiology of the tumors, characterized by a densely fibrotic stroma, rich with immune cell infiltration including macrophages. Macrophages are polarized by environmental cues which dictate their function. In PDA, macrophages within the tumor (tumor associated macrophages, or TAMs) are strongly immunosuppressive, inhibiting both infiltr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 0 publications
1
3
0
Order By: Relevance
“…Next, RAW264.7 macrophages co-cultured in 3D with PyVMT breast cancer displayed changes in redox ratio consistent with metabolic changes from tumor stimulation in previous studies ( Fig 4A&C) (47). Differences in redox ratio and fluorescence lifetime measurements were observed between RAW264.7 macrophages in cytokine-stimulated 2D cultures ( Fig 2B) and tumorstimulated 3D cultures (Fig 4C-E), consistent with reported differences in intracellular metabolite concentration and metabolic flux based on stimulation condition (e.g., cytokines, tumor conditioned media) and culture in 2D vs. 3D (48,49). Additionally, 3D co-cultured RAW264s exhibited heterogeneous cell-level autofluorescence and pooled gene expression ( Fig 4B, F-H).…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Next, RAW264.7 macrophages co-cultured in 3D with PyVMT breast cancer displayed changes in redox ratio consistent with metabolic changes from tumor stimulation in previous studies ( Fig 4A&C) (47). Differences in redox ratio and fluorescence lifetime measurements were observed between RAW264.7 macrophages in cytokine-stimulated 2D cultures ( Fig 2B) and tumorstimulated 3D cultures (Fig 4C-E), consistent with reported differences in intracellular metabolite concentration and metabolic flux based on stimulation condition (e.g., cytokines, tumor conditioned media) and culture in 2D vs. 3D (48,49). Additionally, 3D co-cultured RAW264s exhibited heterogeneous cell-level autofluorescence and pooled gene expression ( Fig 4B, F-H).…”
Section: Discussionsupporting
confidence: 90%
“…Z-scores for each metabolic autofluorescence variable were calculated for passively-and actively-migrating mouse macrophages in co-culture by subtracting the variable mean of the monoculture condition from the variable mean per condition, then dividing by the monoculture standard deviation at each time point (Fig 5F). Multi-class random forest models were generated from all 11 autofluorescence variables to classify passive and active migration in 3D mouse co-cultures across all timepoints (24,48, and 72 hours). High classification accuracy was observed for test data predictions for passive vs. active migration, with an accuracy of at least 85% for all test data predictions ( Fig 5G, Supplementary Fig 3Q).…”
Section: Metabolic Imaging Validation: Macrophage Stimulation In 2d Imentioning
confidence: 99%
“…More and more studies have revealed that stroma not only served as a physical barrier to drug delivery and facilitated chemotherapy resistance, but also supported tumor growth and metastasis (39). Although gemcitabine is presently the standard option in the treatment of pancreatic cancer, stromal components including tumor-associated macrophages have been proven essential in delivering gemcitabine resistance in pancreatic cancer cells (40). Thus, investigating the mechanism of tumor microenvironment and identifying stromal components could impel a deeper understanding and contribute to a better prognosis of pancreatic cancer patients in clinical practice.…”
Section: Discussionmentioning
confidence: 99%
“…KPC mice treated with GEM combination treatments had prolonged survival compared to control mice, indicating that inhibiting macrophage recruitment has the potential to improve current PDAC therapies, as seen with FOLFIRINOX. 104 Özdemir et al used transgenic (Ptf1acre/+;LSL-KrasG12D/+;Tgfbr2flox/flox) mice with deleted αSMA+ myofibroblasts in pancreatic cancer. Myofibroblast depleted tumors did not respond to GEM and resulted in multiple adverse outcomes.…”
Section: Georgetown Scientific Research Journalmentioning
confidence: 99%